(Date:11/4/2009).... 20 Aware, Inc. (Nasdaq...ogy and biometrics software, today reported financ... 30, 2009. ,, Michael Tzannes, Aware,s Chairm...ay, we announced an agreement to sell our DSL and ...less semiconductor company being spun out of Infin...
(Date:11/4/2009)...PRNewswire/ -- Global Rainmakers, Inc., an intelle...D laboratory, today announced that the company has...vely commercialize its suite of technologies desig...ferings. ,, During the past four years, the com...lop and deploy a series of core--but expandable--t...
(Date:11/3/2009)...4, 2009 -- The world,s greatest wines are the res...man input, and something called the "terroir" -- a...d climate. , Experts will discuss terroir with...nesday, Nov. 4 in Pittsburgh. "Terroir: Winegrape...rts at the 2009 Annual Meetings of the American So...
Breaking Biology News(10 mins):Aware, Inc. Reports Third Quarter 2009 Financial Results 2Aware, Inc. Reports Third Quarter 2009 Financial Results 3Aware, Inc. Reports Third Quarter 2009 Financial Results 4Aware, Inc. Reports Third Quarter 2009 Financial Results 5Aware, Inc. Reports Third Quarter 2009 Financial Results 6Aware, Inc. Reports Third Quarter 2009 Financial Results 7Global Rainmakers Brings Cutting-Edge Biometric Security Products to Reality 2Global Rainmakers Brings Cutting-Edge Biometric Security Products to Reality 3Great wines come from great soils 2Polaroid 28R 29 and The Breast Cancer Research Foundation 28R 29 Print Pink 58554 1Polaroid 28R 29 and The Breast Cancer Research Foundation 28R 29 Print Pink 58554 2Intarcia Therapeutics Inc Presents Positive Results of ITCA 650 Phase 1b Study in Type 2 Diabetes at the European Association for the Study of Diabe 14300 1Intarcia Therapeutics Inc Presents Positive Results of ITCA 650 Phase 1b Study in Type 2 Diabetes at the European Association for the Study of Diabe 14300 2Intarcia Therapeutics Inc Presents Positive Results of ITCA 650 Phase 1b Study in Type 2 Diabetes at the European Association for the Study of Diabe 14300 3Intarcia Therapeutics Inc Presents Positive Results of ITCA 650 Phase 1b Study in Type 2 Diabetes at the European Association for the Study of Diabe 14300 4Intarcia Therapeutics Inc Presents Positive Results of ITCA 650 Phase 1b Study in Type 2 Diabetes at the European Association for the Study of Diabe 14300 5Purple Communications Dream Bigger Initiative Honors Cancer Survivor and Deaf Community Activist as Trailblazer 5110 1Purple Communications Dream Bigger Initiative Honors Cancer Survivor and Deaf Community Activist as Trailblazer 5110 2Purple Communications Dream Bigger Initiative Honors Cancer Survivor and Deaf Community Activist as Trailblazer 5110 3Purple Communications Dream Bigger Initiative Honors Cancer Survivor and Deaf Community Activist as Trailblazer 5110 4Purple Communications Dream Bigger Initiative Honors Cancer Survivor and Deaf Community Activist as Trailblazer 5110 5(Date:11/5/2009)...NY, N.J., Nov. 5 DSM Pharmaceutica...facturing alliance with Galenix, Saint Jean D,Illa...ial scale manufacturing partner for Galenix commer...enix will collaborate on business development oppo...ologies, based on the strength of Galenix in drug ...
(Date:11/5/2009)...ORDOVA, Calif., Nov. 5 T...plier of innovative products for processing and st... the first quarter of fiscal 2010. ,, For the q...ted revenues of $5.2 million, a 15 percent increas...er a year ago. The Company said the key contributo...
(Date:11/5/2009)...eb., Nov. 5 Transgenomic...financial results for the quarter ended September ...ented in the tables that follow. ,, Third Quar... $366,000 or $0.01 per share for the third quarter...$0.01 per share for the third quarter of 2008. ,...
(Date:11/5/2009)...E, Calif., Nov. 5 Cephei...ives will be speaking at the following investor co...a webcast. , , Credit Suisse Healt...rsday, 12 November, 2009 at 10 a.m. Mountain Time,..., London, England, Tuesday, 1 Dece...
Breaking Biology Technology:DSM Pharmaceutical Products Forms Manufacturing Alliance With Galenix 2DSM Pharmaceutical Products Forms Manufacturing Alliance With Galenix 3ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 2ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 3ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 4ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 5ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 6ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 7ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 8Transgenomic, Inc. Reports Third Quarter 2009 Results 2Transgenomic, Inc. Reports Third Quarter 2009 Results 3Transgenomic, Inc. Reports Third Quarter 2009 Results 4Transgenomic, Inc. Reports Third Quarter 2009 Results 5Transgenomic, Inc. Reports Third Quarter 2009 Results 6Transgenomic, Inc. Reports Third Quarter 2009 Results 7Cepheid to Webcast Upcoming Financial Presentations 2...Oct. 29 Aloka Co., Ltd., the Innovator in,Ultraso...troduction of two,ultrasound systems with dedicate...ing, the ProSound Alpha 10 and the ProSound Alpha ...ociation, at the Orange County,Convention Center i...und Alpha 7 and the Alpha 10 incorporate all of th...
...s Presented at American Academy of Pediatrics Nati...hibition, SAN FRANCISCO and EAST NORRITON, Pa., O...icine, announced today that findings from,a precli...Academy of,Pediatrics (AAP) National Conference an...n Neo-Bladder Augment(TM) to restore bladder funct...
...K, October 29 XTL Biopharmaceuticals,Ltd. (NASDAQ...t Ron Bentsur,the Company,s Chief Executive Office...dman & Renshaw 9th Annual Health Care Conference. ...y including a discussion of,Bicifadine, the Compan... of,neuropathic pain. Mr. Bentsur,s presentation w...
Other Biology Technology:ALOKA to Introduce New 'ProSound' Diagnostic Ultrasound Systems at the Scientific Session 2007 of American Heart Association, 4th to 7th of November 2007 in Orlando, Florida 2ALOKA to Introduce New 'ProSound' Diagnostic Ultrasound Systems at the Scientific Session 2007 of American Heart Association, 4th to 7th of November 2007 in Orlando, Florida 3Preclinical Efficacy Data Demonstrate Ability of Tengion's Neo-Bladder Augment to Restore Bladder Function 2Preclinical Efficacy Data Demonstrate Ability of Tengion's Neo-Bladder Augment to Restore Bladder Function 3XTL Biopharmaceuticals to Present at the Rodman & Renshaw 9th Annual Health Care Conference 2...o terminus) XAB2 (XPA-binding protein 2) was firs...unoprecipitation experiments have also demonstrate...cription-coupled repair-specific proteins CSA and ...ion experiments with XAB2 antibodies resulted in t...
...oplate coating using advanced automated high throu...es and washes a variety of plate formats. We can a...owing formats (with a volume range of 0.5-320 L):,...late, 384 well microplate, 1536 well mic...
Agarose LE from Ambion
Mynox Mycoplasma Elimination Reagent from Sigma-Aldrich
Biology Products: